# IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

> **NCT01841619** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 16 (actual)

## Conditions studied

- Cutaneous Lupus Erythematosus

## Interventions

- **DRUG:** IVIg

## Key facts

- **NCT ID:** NCT01841619
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841619, "IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01841619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*